46.45

1.74% -0.8107

Crispr Therapeutics Ag (CRSP)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché CRSP Giù? Forum Previsione

Precedente Chiudi:

$47.26

Aprire:

$47.21

Volume 24 ore:

193.82K

Relative Volume:

0.16

Capitalizzazione di mercato:

$4.03B

Reddito:

$170.10M

Utile/perdita netta:

$-239.59M

Rapporto P/E:

-10.39

EPS:

-4.47

Flusso di cassa netto:

$-191.20M

1 W Prestazione:

-0.88%

1M Prestazione:

-4.27%

6M Prestazione:

-15.20%

1 anno Prestazione:

-31.27%

Intervallo 1D:

$46.02

$47.21

Intervallo di 1 settimana:

$46.02

$48.44

Portata 52W:

$43.42

$91.10

Crispr Therapeutics Ag Stock (CRSP) Company Profile

Nome

Crispr Therapeutics Ag

Settore

Healthcare (1195)

Industria

Biotechnology (683)

Telefono

(617) 315-4600

Indirizzo

BAARERSTRASSE 14, ZUG

Dipendente

407

Cinguettio

@crisprtx

Prossima data di guadagno

2024-12-05

Ultimi documenti SEC

CRSP's Discussions on Twitter

Confronta CRSP con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CRSP	46.44	4.03B	170.10M	-239.59M	-191.20M	-4.47
VRTX	447.79	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	742.25	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	590.72	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	248.74	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	102.50	24.49B	3.30B	-501.07M	1.03B	11.54

Crispr Therapeutics Ag Stock (CRSP) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-02-15	Iniziato	Wolfe Research	Peer Perform
2023-12-11	Downgrade	TD Cowen	Market Perform → Underperform
2023-10-17	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2023-09-27	Iniziato	Mizuho	Buy
2023-08-17	Aggiornamento	Citigroup	Neutral → Buy
2023-05-30	Iniziato	William Blair	Outperform
2023-04-13	Iniziato	Cantor Fitzgerald	Overweight
2023-03-21	Iniziato	Bernstein	Mkt Perform
2023-03-17	Iniziato	Bryan Garnier	Buy
2023-03-07	Iniziato	Robert W. Baird	Neutral
2022-10-11	Iniziato	Morgan Stanley	Underweight
2022-08-09	Downgrade	Barclays	Overweight → Equal Weight
2022-06-23	Downgrade	Evercore ISI	Outperform → In-line
2022-06-17	Iniziato	BMO Capital Markets	Outperform
2022-04-28	Iniziato	Credit Suisse	Neutral
2021-12-07	Iniziato	Cowen	Market Perform
2021-10-19	Iniziato	SVB Leerink	Outperform
2021-06-14	Aggiornamento	Citigroup	Sell → Neutral
2021-04-21	Aggiornamento	Jefferies	Hold → Buy
2021-03-04	Iniziato	JMP Securities	Mkt Outperform
2020-12-10	Reiterato	Chardan Capital Markets	Buy
2020-12-10	Downgrade	Jefferies	Buy → Hold
2020-12-10	Reiterato	Needham	Buy
2020-12-07	Downgrade	Wells Fargo	Overweight → Equal Weight
2020-10-23	Iniziato	RBC Capital Mkts	Sector Perform
2020-10-05	Iniziato	BofA Securities	Buy
2020-07-28	Reiterato	Needham	Buy
2020-07-14	Iniziato	SunTrust	Buy
2020-06-15	Reiterato	Canaccord Genuity	Buy
2020-03-05	Iniziato	Stifel	Hold
2020-02-03	Downgrade	Evercore ISI	Outperform → In-line
2019-11-19	Aggiornamento	William Blair	Mkt Perform → Outperform
2019-11-12	Aggiornamento	Oppenheimer	Perform → Outperform
2019-08-01	Iniziato	Jefferies	Buy
2019-07-26	Iniziato	Canaccord Genuity	Buy
2019-06-10	Iniziato	ROTH Capital	Buy
2019-04-12	Iniziato	Evercore ISI	Outperform
2019-03-14	Iniziato	William Blair	Mkt Perform
2019-01-28	Downgrade	Goldman	Buy → Neutral
2019-01-22	Downgrade	Citigroup	Neutral → Sell

Mostra tutto

Crispr Therapeutics Ag Borsa (CRSP) Ultime notizie

Nov 20, 2024

CRISPR Therapeutics Stock Falls 7% in Two Weeks: Time to Hold or Sell? - Yahoo Finance

Nov 20, 2024

Nov 19, 2024

The Best Biotech Stocks to Buy - Morningstar

Nov 19, 2024